Table 3.
Reasons for vaccine rejection and acceptance, along with concerns over vaccine complications
| Responder | Responder | |||
|---|---|---|---|---|
| n = 674 | n = 31 | |||
| Reasons behind vaccine acceptance | Reasons for vaccine hesitancy | |||
| To prevent COVID-19 infection | 473 (70.2%) | Uncertain of vaccine efficacy | 26 (83.9%) | |
| Having high risk of infection from work | 327 (48.5%) | Concerns about side effects | 15 (48.4%) | |
| Organization supports | 271 (40.2%) | Low vaccine safety due to rushed development | 2 (6.5%) | |
| Free of charges | 156 (23.1%) | Low risk of infection, do not need vaccination | 2 (6.5%) | |
| Living in close quarters with someone at high risk | 154 (22.8%) | Low confidence in the vaccine technology | 1 (3.2%) | |
| Peer pressure | 4 (0.6%) | Others | 0 (0.0%) | |
| Others | 0 (0.0%) |
| Total | Yes | No/Not sure | p valuea | |
|---|---|---|---|---|
| n = 705 | n = 674 | n = 31 | ||
| Most concern side effects† | 0.66 | |||
| None | 3 (0.4%) | 3 (0.4%) | 0 (0.0%) | |
| Anaphylaxis | 199 (28.2%) | 192 (28.5%) | 7 (22.6%) | |
| Neurologic complications | 268 (38.0%) | 259 (38.4%) | 9 (29.0%) | |
| Local reaction | 6 (0.9%) | 6 (0.9%) | 0 (0.0%) | |
| Systemic reaction | 21 (3.0%) | 20 (3.0%) | 1 (3.2%) | |
| Long-term side effects | 175 (24.8%) | 163 (24.2%) | 12 (38.7%) | |
| COVID infection | 26 (3.7%) | 24 (3.6%) | 2 (6.5%) | |
| Thromboembolism/VIPIT | 7 (1.0%) | 7 (1.0%) | 0 (0.0%) |
†One best choice question
aFisher exact test